(the company has corrected data in the press release, the proportion subscribed increases to 13 percent)The medical technology company Odinwell states that the board, management, and majority owner Nestero Holding have committed to exercise their warrants of series TO 2, corresponding to about 0.7 million warrants or around 13 percent of the total outstanding warrants. The subscription period runs from May 18 to June 1. Upon full exercise at the highest subscription price, the company can be provided with around SEK 2.5 million before expenses.Odinwell has Carlsquare as adviser.